[ FDA ENFORCEMENT INTELLIGENCE ]
Learn from the record. Every FDA recall is a quality signal.
Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.
1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN
Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.
1,235 matching recalls
| Date | Class | Firm | Reason | Quality domain |
|---|---|---|---|---|
| 2026-07-15 | Class II | Integra LifeSciences Corp. (NeuroSciences)Z-2714-2026 | The current Omni-Tract Surgical Retractor System IFU states a dry time of 30 minutes. Integra LifeSciences has identified that the dry time needs to be extended to 90 minutes, 110 minutes, or 120 minutes depending on the sterilization cycle exposure time used. | Environmental Monitoring |
| 2026-07-15 | Class II | Reliance Life Sciences Private LimitedD-0674-2026 | Lack of Sterility Assurance | Environmental Monitoring |
| 2026-07-15 | Class I | Trafa Pharmaceutical Inc.H-1144-2026 | Potential contamination with Salmonella | Environmental Monitoring |
| 2026-07-15 | Class II | Reliance Life Sciences Private LimitedD-0671-2026 | Lack of Sterility Assurance | Environmental Monitoring |
| 2026-07-15 | Class I | Fresh & Ready Foods LLCH-1149-2026 | Raw breaded chicken patties were inadvertently used in the ready to eat Burger Chicken Fillet sandwich. Raw breaded chicken patties pose a risk of foodborne illness due to the potential presence of Salmonella. | Environmental Monitoring |
| 2026-07-15 | Class II | Reliance Life Sciences Private LimitedD-0673-2026 | Lack of Sterility Assurance | Environmental Monitoring |
| 2026-07-15 | Class I | Fresh & Ready Foods LLCH-1148-2026 | Raw breaded chicken patties were inadvertently used in the ready to eat Burger Chicken Deluxe With Bacon sandwich. Raw breaded chicken patties pose a risk of foodborne illness due to the potential presence of Salmonella. | Environmental Monitoring |
| 2026-07-08 | Class II | Blaine Labs IncD-0699-2026 | CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0651-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | Asclemed USA Inc.D-0659-2026 | Lack of Assurance of Sterility | Environmental Monitoring |
| 2026-07-08 | Class I | Blaine Labs IncD-0692-2026 | Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp | Environmental Monitoring |
| 2026-07-08 | Class II | ACCORD BIOPHARMA INCD-0653-2026 | Lack of assurance of Sterility: | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0644-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0652-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0647-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | MARS SNACKINGH-1130-2026 | Potential contamination with plastic material | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0645-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | Asclemed USA Inc.D-0658-2026 | Lack of Assurance of Sterility | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0643-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | Wells Enterprises, Inc.H-1151-2026 | Elevated coliforms | Environmental Monitoring |
| 2026-07-08 | Class I | NARA ORGANICS INCH-1137-2026 | Product may be contaminated with Clostridium botulinum. | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0649-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | Blaine Labs IncD-0693-2026 | CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated | Environmental Monitoring |
| 2026-07-08 | Class II | MARS SNACKINGH-1129-2026 | Potential contamination with plastic material | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0646-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.